These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25317877)

  • 1. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Canaud G; Terzi F
    N Engl J Med; 2014 Oct; 371(16):1554-5. PubMed ID: 25317877
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Hidalgo LG
    N Engl J Med; 2014 Oct; 371(16):1554. PubMed ID: 25317880
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Zuily S; Regnault V; Wahl D
    N Engl J Med; 2014 Oct; 371(16):1553-4. PubMed ID: 25317879
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Van Laecke S; Nagler EV; Vanholder R
    N Engl J Med; 2014 Oct; 371(16):1553. PubMed ID: 25317878
    [No Abstract]   [Full Text] [Related]  

  • 5. The mTORC pathway in the antiphospholipid syndrome.
    Eikelboom JW; Weitz JI
    N Engl J Med; 2014 Jul; 371(4):369-71. PubMed ID: 25054721
    [No Abstract]   [Full Text] [Related]  

  • 6. Connective tissue diseases: mTORC is a potential therapeutic target in APS.
    Duarte JH
    Nat Rev Nephrol; 2014 Oct; 10(10):544. PubMed ID: 25092152
    [No Abstract]   [Full Text] [Related]  

  • 7. Connective tissue diseases: mTORC is a potential therapeutic target in APS.
    Duarte JH
    Nat Rev Rheumatol; 2014 Sep; 10(9):513. PubMed ID: 25090943
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Canaud G; Bienaimé F; Tabarin F; Bataillon G; Seilhean D; Noël LH; Dragon-Durey MA; Snanoudj R; Friedlander G; Halbwachs-Mecarelli L; Legendre C; Terzi F
    N Engl J Med; 2014 Jul; 371(4):303-12. PubMed ID: 25054716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC Pathway Activation and Effect of Sirolimus on Native Kidney Antiphospholipid Syndrome Nephropathy: A Case Report.
    Dufour I; Venot Q; Aydin S; Demoulin N; Canaud G; Morelle J
    Am J Kidney Dis; 2020 Aug; 76(2):288-291. PubMed ID: 31810732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and the endothelium.
    Hunt BJ; Khamashta MA
    Curr Rheumatol Rep; 2000 Jun; 2(3):252-5. PubMed ID: 11123067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stents Coated With Mammalian Target of Rapamycin Inhibitors (mTOR) Appear to Be the Best Choice in Patients With Antiphospholipid Syndrome and Myocardial Infarction.
    Mora-Ramírez M; González-Pacheco H; Amezcua-Guerra LM
    J Clin Rheumatol; 2016 Aug; 22(5):281. PubMed ID: 27464778
    [No Abstract]   [Full Text] [Related]  

  • 12. [New insights in the antiphospholipid syndrome associated vasculitis: the role of the AKT/mTORC pathway].
    Canaud G
    Rev Med Interne; 2015 Jul; 36(7):439-43. PubMed ID: 25769629
    [No Abstract]   [Full Text] [Related]  

  • 13. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game.
    Canaud G; Legendre C; Terzi F
    Lupus; 2015 Mar; 24(3):227-30. PubMed ID: 25631854
    [No Abstract]   [Full Text] [Related]  

  • 14. Focus.
    Shouval D
    J Hepatol; 2011 Aug; 55(2):243-4. PubMed ID: 21554907
    [No Abstract]   [Full Text] [Related]  

  • 15. TOR-inhibitors as gero-suppressors.
    Nikiforov M
    Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats.
    Renken C; Fischer DC; Kundt G; Gretz N; Haffner D
    Nephrol Dial Transplant; 2011 Jan; 26(1):92-100. PubMed ID: 20615907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More about cellular signaling by antiphospholipid antibodies.
    Lackner KJ
    J Thromb Haemost; 2015 Oct; 13(10):1925-7. PubMed ID: 26302892
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiphospholipid antibodies in patients with retinal vascular occlusions.
    Giordano N; Senesi M; Battisti E; Traversi C; Mattii G; Palumbo F; Gennari C
    Acta Ophthalmol Scand; 1998 Feb; 76(1):128-9. PubMed ID: 9541454
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndrome.
    Sartorelli S; De Luca G; Campochiaro C; Peretto G; Sala S; Esposito A; Busnardo E; Basso C; Thiene G; Dagna L
    Scand J Rheumatol; 2019 Nov; 48(6):515-516. PubMed ID: 30794015
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiphospholipid antibodies and platelets.
    Chong BH; Brighton TC; Chesterman CN
    Semin Thromb Hemost; 1995; 21(1):76-84. PubMed ID: 7604294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.